GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Accumulated Depreciation

AngioLab (XKRX:251280) Accumulated Depreciation : ₩-783.0 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

AngioLab's quarterly accumulated depreciation increased from Dec. 2021 (₩-586.7 Mil) to Dec. 2022 (₩-687.6 Mil) and increased from Dec. 2022 (₩-687.6 Mil) to Dec. 2023 (₩-783.0 Mil).

AngioLab's annual accumulated depreciation increased from Dec. 2021 (₩-586.7 Mil) to Dec. 2022 (₩-687.6 Mil) and increased from Dec. 2022 (₩-687.6 Mil) to Dec. 2023 (₩-783.0 Mil).


AngioLab Accumulated Depreciation Historical Data

The historical data trend for AngioLab's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Accumulated Depreciation Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation
Get a 7-Day Free Trial -383.52 -486.15 -586.66 -687.64 -783.00

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated Depreciation Get a 7-Day Free Trial -383.52 -486.15 -586.66 -687.64 -783.00

AngioLab Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


AngioLab Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of AngioLab's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab (XKRX:251280) Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines